Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 3. Отображено 3.
04-07-2023 дата публикации

Kit and system for predicting applicability of platinum-containing neoadjuvant therapy to middle and advanced tumor patients

Номер: CN116377077A
Автор: SUI QIHAI, JIN XING, BIAN YUNYI, ZHANG HUAN, ZHAN CHENG, LIN ZONGWU, WANG QUN
Принадлежит:

The invention provides a kit and a system for predicting applicability of platinum-containing neoadjuvant therapy to middle and advanced tumor patients, and belongs to the technical field of biological medicine. The invention provides application of a quantitative detection reagent for RNA expression quantity of a molecular marker in tumor tissue to preparation of a kit for predicting applicability of platinum-containing new adjuvant therapy to middle and advanced tumor patients, and is characterized in that the molecular marker comprises one or more of CD24, D9, DUSP23, KRT19, LRRK2, MAL2, PERP, SPINT2, TACSTD2, TSPAN13, C8orf4, FMO5, CAPN8, MDK, SLC20A1, SPINK13, TANC2, CLDN3, RGMB, S100P, MUC4, C19 and f33. According to the gene expression quantity of the molecular marker such as CD24 in the tumor tissue, whether the middle and advanced tumor patients can benefit from platinum-containing neoadjuvant therapy or not is predicted, a judgment basis is provided for personalized tumor therapy ...

Подробнее
Номер записи: 1
14-10-2015 дата публикации

Actuating system of mincer

Номер: CN0204699795U
Автор: LIN ZONGWU
Принадлежит:

The utility model belongs to the technical field of the technique of mincer and specifically relates to an actuating system of mincer is related to, the motor is installed in the organism through a side -mounting mainboard of the main shaft at the motor, one side of motor is equipped with the installation subplate, and the main shaft passes the installation subplate and passes the spindle nose of installing the subplate and is equipped with the operator piece, fixedly on installation mainboard and the main shaft of installation between the subplate be equipped with main drive gear, the cover is equipped with the installation cover on the main shaft between main drive gear and the spindle nose, and the installation of passing the installation subplate is sheathe in and is equipped with vice blade, the installation mainboard with install installation between the subplate and sheathe in to fix and be equipped with vice drive gear, main drive gear rotates through the vice drive gear of gear ...

Подробнее
Номер записи: 2
10-06-2015 дата публикации

Applications of CALML3 (Calmodulin-like 3), MLPH (Melanophilin), TMC5 (Transmembrane Channel-like) and SFTA3 (Surfactant Associated 3) in pathological diagnosis of squamous cell lung carcinoma and adenocarcinoma

Номер: CN104698191A
Автор: ZHAN CHENG, WANG QUN, JIANG WEI, LIN ZONGWU, SHI YU, ZHANG YONGXING, XI JUNJIE, YAN LI, SUN YANG, WANG XINGXING, WANG LIN, CHEN LI, JIN YULIN
Принадлежит:

The invention relates four genes, such as CALML3 (Calmodulin-like 3), MLPH (Melanophilin), TMC5 (Transmembrane Channel-like) and SFTA3 (Surfactant Associated 3) or applications of detection reagents thereof, wherein the four genes are used for preparing a differential diagnosis reagent for squamous cell lung carcinoma and adenocarcinoma. According to the applications provided by the invention, mRNA (Messenger Ribonucleic Acid) sequencing results of the squamous cell lung carcinoma and the adenocarcinoma in a TCGA (The Cancer Genome Atlas) database are conducted for statistical analysis, and the data of 490 squamous cell lung carcinoma cases and 490 adenocarcinoma cases are included to discover that the genetic expressions of the CALML3, the MLPH, the TMC5 and the SFTA3 are significantly different, therefore the CALML3, the MLPH, the TMC5 and the SFTA3 are applicable to the differential diagnosis of the squamous cell lung carcinoma and the adenocarcinoma; then, an immunohistochemical way ...

Подробнее
Номер записи: 3